However, when subgroup analysis was performed according to LN status, high CD24 expression was associated with significantly shorter DFS (P = 0.043) and OS (P = 0.012) in early-stage breast cancer for pN0/N1 tumours but not pN2/N3 tumours (Fig 2B). This evidence concerns the gene CD24 and breast cancer.